Clinical trials sponsored by European Institute of Oncology

Phase breakdown

Conditions studied

Recruiting trials led by European Institute of Oncology

• All-in-One Prostate Cancer Staging with MRI
  NCT06071195 · Phase: Not specified · Ages: 35 Years and older · Sex: Male · 3 locations
• Analysis of Circulating Tumor DNA (ctDNA) in HER2-low Advanced/Metastatic Breast Cancer
  NCT06706557 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 1 location
• Atezolizumab and Chemotherapy Treatment as T-cell Activators in Metastatic Triple Negative Breast Cancer Patients
  NCT06690840 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Cognitive Screening in Lung Cancer Patients
  NCT06727370 · Phase: Not specified · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• CompArative Analysis Between, Thymic, pulmonaRy and Pancreatic Well Differentiated High Grade Neuroendocrine Tumors
  NCT07429851 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• CyberKnife Ultra-hypofractionated SBRT for Localized PROStatE cancEr
  NCT06331013 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: Male · 1 location
• Elacestrant and Exemestane for Patients With Pretreated HR+/HER2- Metastatic Breast Cancer and [18F] FES-avid Lesions (COMBINE)
  NCT07395336 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Endoscopic Video-Assisted Nipple-Sparing Mastectomy
  NCT07579117 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Exploring the Tumor Micro-Environment with 68Ga-FAPi-46 PET/CT in Breast Cancer
  NCT06790264 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• IMproving PAtient UndeRstanding of GEP TEst Results: Phase 4
  NCT06703567 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Impact of Augmented Reality During Robot-assisted Radical Prostatectomy
  NCT06059859 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: Male · 1 location
• Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients
  NCT06726889 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Integrated Testing Strategy for Simultaneous Detection of ESR-1 and gBRCA Mutations Via Liquid Biopsy in HR+/HER2- Metastatic Breast Cancer (mBC) Patients,
  NCT06762483 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 1 location
• Lymphedema Evaluation After Adjuvant Hypofractionated Radiotherapy for 1-2 Macrometastatic Sentinel Lymph Nodes
  NCT06321653 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer
  NCT05974475 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Microbiome, Immune-system and Tumor Interaction in Colorectal Cancer
  NCT06331988 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Patient Anxiety During Magnetic Resonance Imaging
  NCT07671846 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients With Chest Wall Breast Cancer
  NCT03971045 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Percutaneous Cryoablation of Low-risk Early Breast Cancer
  NCT06300125 · Phase: Not specified · Ages: 50 Years and older · Sex: All (male and female) · 1 location
• Personalization of External Beam Radiation Therapy in Localised Tumours
  NCT07047495 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Response Evaluation of Cancer Therapeutics in Metastatic Castration-Resistant Prostate Cancer to the Bone
  NCT06321679 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · 1 location
• Single Fraction Preoperative Radiotherapy for Early Stage Breast Cancer
  NCT04679454 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Surgical Outcome Of da Vinci Single-port Surgical System In Lung Cancer
  NCT07790406 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Toxicity Markers to Trastuzumab-Deruxtecan (T-DXd) In Patients With Advanced Breast Cancer
  NCT07049133 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is European Institute of Oncology recruiting for?

European Institute of Oncology is the lead sponsor of 24 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.